Trials / Unknown
UnknownNCT01501968
Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Ascorbic acid (Vitamin C) could protect renal toxicity from colistin.
Detailed description
Renal toxicity due to colistin therapy is common. Ascorbic acid (vitamin C) has been shown to prevent colistin associated renal toxicity in animals. This study is conducted to determine if acorbic acid can prevent Colistin-Associated Nephrotoxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colistin | Colistimethate sodium 2.5-5mg/kg iv per day |
| DRUG | Colistin + Ascorbic acid | Colistimethate sodium 2.5-5mg/kg iv per day and ascorbic acid 2 grams iv q 12 hours |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2011-12-30
- Last updated
- 2011-12-30
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01501968. Inclusion in this directory is not an endorsement.